CVE & CISA-KEV Catalog

CVE-2015-3956

CRITICAL
9.8
CVSS v3
NVD

Description

Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior accept drug libraries, firmware updates, pump commands, and unauthorized configuration changes from unauthenticated devices on the host network. Hospira recommends that customers close Port 20/FTP and Port 23/TELNET on the affected devices. Hospira has also released the Plum 360 Infusion System which is not vulnerable to this issue.

How to fix

No published remediation has been found for this vulnerability's affected products yet.

Mitigation guidance may be in the linked vendor advisories in the References section below.

CVSS v3 Vector

Exploitability

Attack VectorNetwork
Attack ComplexityLow
Privileges RequiredNone
User InteractionNone
ScopeUnchanged

Impact

ConfidentialityHigh
IntegrityHigh
AvailabilityHigh

CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Exploit Intelligence

0.95%probability of exploitation in 30 days
57thpercentile

Moderate risk: more likely to be exploited than 57% of all known CVEs.

References

Embed a live status badge for CVE-2015-3956
CVE-2015-3956 severity badge

Markdown

[![CVE-2015-3956](https://tridentstack.com/cve/badge/CVE-2015-3956.svg)](https://tridentstack.com/cve/CVE-2015-3956)

HTML

<a href="https://tridentstack.com/cve/CVE-2015-3956"><img src="https://tridentstack.com/cve/badge/CVE-2015-3956.svg" alt="CVE-2015-3956"></a>

Find and fix vulnerabilities across your fleet

TridentStack Control continuously scans your Windows, macOS, and Linux fleet for known vulnerabilities, prioritizes them by severity and active exploitation, and patches them automatically.

Start free

This product uses NVD data but is not endorsed or certified by the NVD. EPSS scores courtesy of FIRST.org (https://www.first.org/epss). Source: CISA KEV Catalog. Data as of 2024-11-21.